Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharm-country symbols : Ctxr save search
Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -100.0%
H: NaN%
C: Infinity%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.5%
H: 0.83%
C: 0.28%
CTXR | $0.7477 -7.18% -7.73% 1.7M
|
Health Technology
|
| O: 2.33%
H: 2.28%
C: -4.23%
hope treatment pharmaceuticals city for car-t trial
Citius Pharmaceuticals to Present at the LD Micro Invitational XIV Investor Conference
Published: 2024-04-04 (Crawled : 19:00) - biospace.com/
CTXR | $0.7477 -7.18% -7.73% 1.7M
|
Health Technology
|
| O: -0.51%
H: 3.13%
C: -1.23%
conference pharmaceuticals
Citius Pharmaceuticals, Inc. Secures $2.4 million through New Jersey Economic Development Program
Published: 2024-03-07 (Crawled : 14:30) - biospace.com/
CTXR | $0.7477 -7.18% -7.73% 1.7M
|
Health Technology
|
| O: 0.7%
H: 4.13%
C: 3.61%
million program
Citius Pharmaceuticals to Participate in the Sidoti Micro-Cap Virtual Conference on November 15, 2023
Published: 2023-11-09 (Crawled : 15:30) - biospace.com/
CTXR | $0.7477 -7.18% -7.73% 1.7M
|
Health Technology
|
| O: -1.55%
H: 1.84%
C: 1.32%
conference pharmaceuticals
Citius Pharmaceuticals to be Added to Russell 3000® and Russell 2000® Indexes
Published: 2023-06-26 (Crawled : 13:20) - biospace.com/
CTXR | $0.7477 -7.18% -7.73% 1.7M
|
Health Technology
|
| O: 1.55%
H: 6.87%
C: 3.82%
3000 pharmaceuticals
Citius Pharmaceuticals to Participate in the 35th Annual Roth Conference
Published: 2023-03-08 (Crawled : 17:00) - biospace.com/
CTXR | $0.7477 -7.18% -7.73% 1.7M
|
Health Technology
|
| O: 4.42%
H: 3.39%
C: -5.08%
pharmaceuticals conference
Citius Pharmaceuticals to Present at the Sidoti Micro-Cap Virtual Conference on January 18, 2023
Published: 2023-01-11 (Crawled : 14:00) - biospace.com/
CTXR | $0.7477 -7.18% -7.73% 1.7M
|
Health Technology
|
| O: 0.0%
H: 8.01%
C: 7.1%
pharmaceuticals conference
Citius Pharmaceuticals, Inc. Secures $3.6 million through New Jersey Economic Development Program
Published: 2022-11-21 (Crawled : 14:00) - biospace.com/
CTXR | $0.7477 -7.18% -7.73% 1.7M
|
Health Technology
|
| O: 3.6%
H: 0.87%
C: 0.87%
program
Citius Pharmaceuticals, Inc. Submits Biologics License Application to the U.S. Food and Drug Administration for Denileukin Diftitox for the Treatment of Patients with Persistent or Recurrent Cutaneous T-Cell Lymphoma
Published: 2022-09-28 (Crawled : 13:00) - biospace.com/
CTXR | $0.7477 -7.18% -7.73% 1.7M
|
Health Technology
|
| O: 1.69%
H: 5.83%
C: 0.83%
treatment drug t-cell application license food
Citius Pharmaceuticals, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-07 (Crawled : 22:00) - biospace.com/
CTXR | $0.7477 -7.18% -7.73% 1.7M
|
Health Technology
|
| O: 0.0%
H: 4.1%
C: 2.46%
global conference
Citius Pharmaceuticals, Inc. Announces Intention to Spinoff Late-Stage Oncology Asset, I/ONTAK, into a New Standalone Publicly Traded Company
Published: 2022-05-25 (Crawled : 16:00) - biospace.com/
CTXR | $0.7477 -7.18% -7.73% 1.7M
|
Health Technology
|
| O: 3.4%
H: 3.0%
C: -7.96%
Citius Pharmaceuticals Enrolls First Patient in Phase 2b Study of Halo-Lido for the Prescription Treatment of Hemorrhoids
Published: 2022-04-26 (Crawled : 14:20) - biospace.com/
CTXR | $0.7477 -7.18% -7.73% 1.7M
|
Health Technology
|
| O: -0.9%
H: 3.64%
C: -0.91%
treatment hemorrhoids enroll phase 2b
Citius Pharmaceuticals to Present at the NobleCon18 Investor Conference on April 20, 2022
Published: 2022-04-14 (Crawled : 15:00) - biospace.com/
CTXR | $0.7477 -7.18% -7.73% 1.7M
|
Health Technology
|
| O: 0.0%
H: 2.51%
C: -0.64%
conference
Citius Pharmaceuticals, Inc. Provides First Half 2021 Business Update, Highlights Upcoming Milestones
Published: 2021-07-07 (Crawled : 14:00) - biospace.com/
CTXR | $0.7477 -7.18% -7.73% 1.7M
|
Health Technology
|
| O: -1.25%
H: 9.23%
C: 4.55%
milestone
Citius Pharmaceuticals to be Added to Russell 2000® Index
Published: 2021-06-07 (Crawled : 14:00) - biospace.com/
CTXR | $0.7477 -7.18% -7.73% 1.7M
|
Health Technology
|
| O: 3.43%
H: 10.37%
C: 5.81%
Citius Pharmaceuticals, Inc. Reports Second Fiscal Quarter 2021 Financial Results and Provides General Business Update
Published: 2021-05-13 (Crawled : 12:15) - biospace.com/
CTXR | $0.7477 -7.18% -7.73% 1.7M
|
Health Technology
|
| O: -0.48%
H: 1.06%
C: -9.13%
financial results results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.